There is a growing understanding of the role of inflammation, the immune system, and the development of atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF). Opportunities for the development of new therapeutics targeting inflammation that may reduce the burden of heart disease are emerging. In this series, we will review the clinical trial data and learn more about the interactions of inflammation and heart disease.
Videos in the Series
Funding support provided by Novo Nordisk. Novo Nordisk did not review the content.
About CardioBites
CardioBites are mobile-friendly, bite-sized videos providing focused education on important topics in the heart failure field. They can be watched anytime, anywhere on YouTube. No password. No barriers. Just easy access. Each CardioBites series is designed to educate physicians, scientists, nurses, nurse practitioners, pharmacists, and patients about the recent advances and emerging trends in Heart Failure. Learn More.